Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

TREATMENT.COM AI INC. APPOINTS CHIEF FINANCIAL OFFICER

February 07, 2024 at 08:30 AM EST

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Vancouver, BC, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is pleased to announce the appointment of Mr. David Worner as Chief Financial Officer of the Company, effective February 5, 2024.

Mr. Worner is currently the Chief Executive Officer & Founder of GrowthPath Partners, a transactional accounting & advisory firm that services companies going through mergers and acquisitions and public offering events. Prior to founding GrowthPath, Mr. Worner was a Partner at NOW CFO, an outsourced chief financial officer and financial consulting firm. Prior to NOWCFO, Mr. Worner has worked at private-equity backed and public companies. Mr. Worner started his career in public accounting. Mr. Worner earned an undergraduate degree in Accounting from the University New Orleans.

“We are very excited to add David’s expertise at this critical inflection point in our company’s life cycle. Treatment AI has moved into the commercialization phase and a period of rapid growth,” states Dr. Essam Hamza, CEO. The Company would like to thank Mr. Dong Shim for his years’ of service to the Company and wish him all the best in his future endeavours.”

FOR ADDITIONAL INFORMATION, CONTACT:

Dr. Essam Hamza, CEO ehamza@treatment.com

(612) 788-8900